Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • MANAGING INVASIVE FUNGAL INFECTIONS DURING ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION: A 2025 UPDATE

    Martina Quattrone, Alessia Di Pilla, Sara Brunetti, Antonio Giordano, Luana Fianchi, Livio Pagano, Marianna Criscuolo
    e2025064
    2025-08-31
    https://doi.org/10.4084/MJHID.2025.064
    2279
    PDF: 948
    HTML: 259
  • IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

    İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc
    e2022074
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.074
    1620
    PDF: 808
    HTML: 223
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2921
    PDF: 872
    HTML: 6538
    Untitled: 250
    Untitled: 203
    Untitled: 224
    Untitled: 231
  • Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

    Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni
    e2013048
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.048
    1590
    PDF: 697
    HTML: 1926
  • GOOD OUTCOME FOR VERY HIGH RISK ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA CARRYING GENETIC ABNORMALITIES t(4;11)(q21;q23) or t(9;22)(q34;q11), IF PROMPTLY SUBMITTED TO ALLOGENEIC TRANSPLANTATION, AFTER OBTAINING A GOOD MOLECULAR REMISSION.

    Matteo Parma, Clara Vigano', Monica Fumagalli, Federica Colnaghi, Arianna Colombo, Federica Mottadelli, Vincenzo Rossi, Elena Elli, Elisabetta Terruzzi, Angelo Belotti, Giovanni Cazzaniga, Enrico Maria Pogliani, Pietro Pioltelli
    e2015041
    2015-05-26
    https://doi.org/10.4084/mjhid.2015.041
    2247
    PDF: 1044
    HTML: 1191
  • Osteolytic bone lesions – A rare presentation of AML M6.

    Geetha N., Sreelesh KP, Priya Mary Jacob, Lali VS, Rekha A Nair
    e2015017
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.017
    2023
    PDF: 1125
    HTML: 7958
    Untitled: 208
  • BASELINE THROMBIN GENERATION TEST DOES NOT PREDICT THROMBOTIC EVENTS IN ACUTE LEUKEMIA: A MONOCENTRIC PROSPECTIVE STUDY

    Mario Biglietto, Rosaria Mormile, Maria Laura Bisegna, Alessandro Laganà, Anna Laura Faccini, Andrea Papa, Erminia Baldacci, Cristina Santoro, Maria Stefania De Propris, Antonio Chistolini
    e2025076
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.076
    434
    PDF: 214
    Html: 59
  • Acquired von Willebrand Syndrome associated to secondary IgM MGUS emerging after Autologous Stem Cell Transplantation for AL Amyloidosis

    Victor H Jimenez-Zepeda, Hina Qamar, Adrienne Lee, Karen Valentine, Leslie Skeith
    e2017034
    2017-05-01
    https://doi.org/10.4084/mjhid.2017.034
    2691
    PDF: 1058
    HTML: 1179
  • DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA

    Sabina Chiaretti, Gina Zini, Renato Bassan
    e2014073
    2014-10-24
    https://doi.org/10.4084/mjhid.2014.073
    9209
    PDF: 6137
    HTML: 87988
    Fig.1b: 197
    Fig.1c: 204
    Fig.2a: 190
    Fig.2b: 190
    Fig.4: 206
    Fig.2c: 194
    Fig.3: 195
    Tab.1: 246
    Tab.2: 220
    Tab.3: 205
    Tab.4: 240
    Fig1a: 200
  • OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.

    Shuvra Neel Baul, Rajib De, PRAKAS KUMAR MANDAL, Swagnik Roy, Tuphan Kanti Dolai, Prantar Chakrabarti
    e2018051
    2018-09-01
    https://doi.org/10.4084/mjhid.2018.051
    2287
    PDF: 954
    HTML: 429
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 231
    UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 358
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 259
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 189
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 200
    Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 272
  • PROGNOSTIC VALUE OF BRAIN AND ACUTE LEUKEMIA CYTOPLASMIC GENE EXPRESSION IN EGYPTIAN CHILDREN WITH ACUTE MYELOID LEUKEMIA

    adel abd elhaleim hagag
    e2015033
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.033
    2139
    PDF: 845
    HTML: 1152
  • Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF

    Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
    e2022025
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.025
    1814
    PDF: 588
    HTML: 304
  • Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Devika Gupta
    e2013042
    2013-06-04
    https://doi.org/10.4084/mjhid.2013.042
    3249
    PDF: 986
    HTML: 3140
    flowcytometric result of peripheral blood sample: 187
  • ROLE OF BIOMARKERS AS PREDICTORS OF INFECTION AND DEATH IN NEUTROPENIC FEBRILE PATIENTS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION.

    Karim Massaro, Silvia F Costa
    e2015059
    2015-10-15
    https://doi.org/10.4084/mjhid.2015.059
    2173
    PDF: 1010
    HTML: 1728
  • ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

    Lourdes Vazquez
    e2016040
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.040
    4372
    PDF: 1401
    HTML: 2064
  • CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL

    Abdolreza Sotoodeh Jahromi, Mohammad Kargar, Farshid Kafilzadeh, Marzieh Jamalidoust, Maliheh Moradzadeh
    e2021049
    2021-06-28
    https://doi.org/10.4084/MJHID.2021.049
    1325
    PDF: 513
    HTML: 208
  • COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

    Afadil Adam
    e2020070
    2020-08-29
    https://doi.org/10.4084/mjhid.2020.070
    1749
    PDF: 1148
    HTML: 299
  • Impact of daratumumab on stem cell mobilization and transplant in patient with newly diagnosed multiple myeloma: a real word single-center study

    Mauro Passucci, Francesca Fazio, Jacopo Micozzi, Manhaz Shafii Bafti, Giovanni Manfredi Assanto, Alfonso Piciocchi, Maurizio Martelli, Maria Teresa Petrucci
    e2024041
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.041
    1281
    PDF: 1071
    Suppl. Files: 718
    HTML: 80
  • ROLE OF STEM CELL FACTOR IN THE REACTIVATION OF HUMAN FETAL HEMOGLOBIN

    Marco Gabbianelli, Ugo Testa
    e2009009
    2009-11-12
    1175
    PDF: 484
    HTML: 4498
  • COMPARISON OF EMPIRIC ANTIBIOTIC ESCALATION THERAPY WITH VANCOMYCIN (VAN) VERSUS LINEZOLID (LIN) IN PATIENTS WITH FEBRILE NEUTROPENIA

    Karin Mayer, Nicolaus Hegge, Ernst Molitor, Peter Brossart, Corinna Hahn-Ast
    e2022032
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.032
    1122
    PDF: 553
    HTML: 221
  • COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

    Federico Mercolini, Simone Cesaro
    e2022009
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.009
    2573
    PDF: 960
    HTML: 324
  • COMPARISON OF PRESEPSIN, PROCALCITONIN, INTERLEUKIN-8 AND C-REACTIVE PROTEIN IN PREDICTING BACTERAEMIA IN FEBRILE NEUTROPENIC ADULT PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES

    Irena Kostic, Carmela Gurrieri, Elisa Piva, Gianpietro Semenzato, Mario Plebani, Ilaria Caputo, Fabrizio Vianello
    e2019047
    2019-08-29
    https://doi.org/10.4084/mjhid.2019.047
    1827
    PDF: 1298
    HTML: 374
  • Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.

    Salvatore Perrone, Chiara Lisi, Elettra Ortu La Barbera, Cristina Luise, Miriam Lichtner, Corrado Girmenia, Giuseppe Cimino
    e2020026
    2020-04-27
    https://doi.org/10.4084/mjhid.2020.026
    1533
    PDF: 827
    HTML: 339
  • ASSESSMENT OF OBESITY AND HEPATIC LATE ADVERSE EFFECTS IN THE EGYPTIAN SURVIVORS OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA: SINGLE CENTER STUDY

    Farida El-Rashedy, Mahmoud Ahmed El-Hawy, Sally El Hefnawy, Mona Mohammed
    e2017026
    2017-04-15
    https://doi.org/10.4084/mjhid.2017.026
    2542
    PDF: 930
    HTML: 1308
    Untitled: 237
  • Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission

    Beatrice Borsellino, Arianna Savi, Maria Rosaria Pascale, Elisa Meddi, Antonio Cristiano, TIZIANA OTTONE, Maria Cristina Rapanotti, Mariadomenica Divona, SERENA TRAVAGLINI, Enrico Attardi, Elisa Buzzatti, Francesco Buccisano, Maria Teresa Voso
    e2022058
    2022-06-29
    https://doi.org/10.4084/MJHID.2022.058
    1716
    PDF: 799
    HTML: 267
  • "ROLE OF ALLOGENEIC TRANSPLANTATION IN MULTIPLE MYELOMA IN THE ERA OF NEW DRUGS"

    Benedetto Bruno, Luisa Giaccone, Moreno Festuccia, Mario Boccadoro
    e2010013
    2010-06-01
    https://doi.org/10.4084/mjhid.2010.013
    1477
    PDF: 674
    HTML: 1519
  • Massive pulmonary embolism at the onset of acute promyelocytic leukemia

    Federica Sorà, Patrizia Chiusolo, Luca Laurenti
    e2016027
    2016-07-01
    https://doi.org/10.4084/mjhid.2016.027
    3569
    PDF: 908
    HTML: 1670
    figure 1: 174
    Untitled: 201
  • PROGNOSTIC SIGNIFICANCE OF NRAS GENE MUTATIONS IN CHILDREN WITH ACUTE MYELOGENOUS LEUKEMIA

    Rabab Aly, Mohamed R. El-sharnoby, Adel A. Hagag
    e2011055
    2011-11-28
    https://doi.org/10.4084/mjhid.2011.055
    1913
    PDF: 769
    HTML: 1546
  • Bacillus Cereus catheter related bloodstream infection in a patient in a patient with acute lymphblastic leukemia

    Lütfiye Öksüz, N Gurler, M Muftuoglu, FD Sargin, SK Besisik
    e2012004
    2012-01-18
    https://doi.org/10.4084/mjhid.2012.004
    1647
    PDF: 1126
    HTML: 1089
  • A Case of Rupioid Syphilis Masquerading as Aggressive Cutaneous Lymphoma

    Jonathan Braue, Thomas Hagele, Abraham Tareq Yacoub, Suganya Mannivanan, Frank Glass, Lubomir Sokol, John Norman Greene
    e2015026
    2015-04-19
    https://doi.org/10.4084/mjhid.2015.026
    2324
    PDF: 1046
    HTML: 5081
    Cover Letter: 175
    Figure 2: 173
    Figure 1: 182
    Figure 3: 208
    Figure 4: 179
    Figure Legend: 193
    Table 1: 200
    Table 2: 192
    Table 3: 191
  • Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

    Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso
    e2024048
    2024-04-30
    https://doi.org/10.4084/MJHID.2024.048
    1055
    PDF: 1002
    HTML: 158
  • COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA.

    Monia Marchetti , Robert Peter Gale, Giovanni Barosi
    Page e2021034
    2021-04-29
    https://doi.org/10.4084/MJHID.2021.034
    1495
    PDF: 548
    HTML: 201
  • NOVEL DRUGS IN FOLLICULAR LYMPHOMA

    Giuseppe Rossi, Antonella Anastasia
    e2016061
    2016-11-01
    https://doi.org/10.4084/mjhid.2016.061
    4499
    PDF: 1538
    HTML: 1565
    Untitled: 243
  • TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.

    Aditi Singh, MD, Ishaq Asghar, MD, Laura Kohler, DO, Hosam Hakim, MD, Daniel Snower, MD, Daniel Lebovic, MD
    e2022018
    2022-02-27
    https://doi.org/10.4084/MJHID.2022.018
    1927
    PDF: 793
    HTML: 547
  • TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi, Dr. Galli, Prof. Patrizia Chiusolo
    e2025039
    2025-04-30
    https://doi.org/10.4084/MJHID.2025.039
    2365
    PDF: 1673
    HTML: 305
  • GENETIC PREDISPOSITION TO HEMATOLOGIC MALIGNANCIES IN CHILDHOOD AND ADOLESCENCE

    Francesco Fabozzi, Angela Mastronuzzi
    e2023032
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.032
    2034
    PDF: 530
    HTML: 594
  • COMPARISON OF THE POWER OF PROCALCITONIN AND C-REACTIVE PROTEIN TO DISCRIMINATE BETWEEN DIFFERENT AETIOLOGIES OF FEVER IN PROLONGED PROFOUND NEUTROPENIA: A SINGLE-CENTRE PROSPECTIVE OBSERVATIONAL STUDY.

    Anke Verlinden, Veronique De Vroey, Herman Goossens, Ella Roelant, Ann Van de Velde, Zwi Berneman, Wilfried Schroyens, Alain Gadisseur
    e2019023
    2019-02-26
    https://doi.org/10.4084/mjhid.2019.023
    6802
    PDF: 1106
    HTML: 456
  • CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA

    Neryal Tahta, Tuba Hilkay Karapınar, Sultan Okur Acar, Ayşe Erol, İlker Devrim, Yesim Oymak, Salih Gozmen, Canan Raziye Vergin
    e2026004
    2026-01-01
    https://doi.org/10.4084/MJHID.2026.004
    953
    PDF: 711
    HTML: 120
  • OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION

    Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz
    e2012011
    2012-02-10
    https://doi.org/10.4084/mjhid.2012.011
    1149
    PDF: 554
    HTML: 1702
    Figures: 179
    Fifures Sanz: 187
    tables Sanz: 188
    Untitled: 185
  • A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

    Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi
    e2024013
    2024-01-01
    https://doi.org/10.4084/MJHID.2024.013
    1028
    PDF: 1186
    HTML: 167
  • HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

    Mazyar Shadman, Joachim Deeg
    e2014056
    2014-09-01
    https://doi.org/10.4084/mjhid.2014.056
    2084
    PDF: 784
    HTML: 3119
  • The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones

    Antonio Cristiano, Raffaele Palmieri, Emiliano Fabiani, Tiziana Ottone, Mariadomenica Divona, Arianna Savi, Francesco Buccisano, Luca Maurillo, Corrado Tarella, William Arcese, Maria Teresa Voso
    e2022041
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.041
    1304
    PDF: 781
    HTML: 327
  • DISTRIBUTION OF DIFFERENT PML/RAR? BCR ISOFORMS IN INDIAN ACUTE PROMYELOCYTIC LEUKAEMIA (APL) PATIENTS AND CLINICOHEMATOLOGICAL CORRELATION

    Tathagata Chatterjee, Srishti Gupta, Ajay Sharma, Sanjeevan Sharma, Prosenjit Ganguli
    e2014004
    2013-12-31
    https://doi.org/10.4084/mjhid.2014.004
    1522
    PDF: 929
    HTML: 2219
    Response to reviewers comments: 195
  • RECENT ADVANCES IN THE 5Q- SYNDROME

    Andrea Pellagatti, Jacqueline Boultwood
    e2015037
    2015-05-20
    https://doi.org/10.4084/mjhid.2015.037
    2847
    PDF: 1850
    HTML: 3691
    Pellagatti Fig 1: 227
    Pellagatti Fig. 2: 219
  • Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

    Mauro Passucci, Giovanni Assanto, Alessandro Pulsoni
    e2023018
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.018
    1289
    PDF: 933
    HTML: 368
  • THROMBOTIC MICROANGIOPATHY IN HAEMATOPOIETIC CELL TRANSPLANTATION:AN UPDATE

    Evi Stavrou, Hillard Michael Lazarus
    e2010033
    2010-10-29
    https://doi.org/10.4084/mjhid.2010.033
    1645
    PDF: 1081
    HTML: 10489
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4492
    PDF: 1371
    HTML: 2170
  • THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

    Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra
    e2011031
    2011-07-08
    https://doi.org/10.4084/mjhid.2011.031
    2320
    PDF: 964
    HTML: 2407
  • THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA

    Yingying Li, Yang Li, Wenguo Cheng
    e2025073
    2025-10-31
    https://doi.org/10.4084/MJHID.2025.073
    523
    PDF: 260
    HTML: 104
  • GILTERITINIB (XOSPATA ®) IN TURKEY: EARLY ACCESS PROGRAM RESULTS Gilteritinib (XOSPATA ®) in Turkey

    Mehmet Hilmi DOGU, Ali Irfan Emre TEKGUNDUZ, Burak DEVECI, Gulten KORKMAZ, Melda COMERT, Omur Gokmen SEVINDIK, Osman YOKUS, Istemi SERIN
    e2023031
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.031
    1496
    PDF: 922
    Suppl. Files: 462
    HTML: 248
101 - 150 of 228 items << < 1 2 3 4 5 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.